omega-3 fatty acids and non-alcoholic fatty liver disease

Authors

مهدی فروغی

دانشجوی کارشناس ارشد، کمیته تحقیقات دانشجویی، مرکز تحقیقات امنیت غذایی، گروه تغذیه جامعه، دانشکده تغذیه و علوم غذایی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران لیلا آزادبخت

دانشیار، مرکز تحقیقات امنیت غذایی، گروه تغذیه جامعه، دانشکده تغذیه و علوم غذایی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران

abstract

background: omega-3 fatty acids have established beneficial effects for cardiovascular disease. the use of omega-3 supplements for patients with non-alcoholic fatty liver disease (nafld) was proposed. the purpose of this study was to review the relationship between omega-3 fatty acids intake and nafld. methods: in this study, the terms such as nafld, omega-3 fatty acids, docosahexanoic acid, and eicosapentanoic acid were searched in pubmed search engine. 15 studies on nafld and omega-3 were found. four of these studies were not fully available. three studies were not strong in terms of design. therefore, 8 studies were chosen. findings: the results showed that omega-3 is a regulator of gene expression in the liver. human studies have established that consumption of omega-3 have a role in reducing the hepatic steatosis, improving insulin sensitivity and decrease the inflammatory marker. more clinical trials should be conducted to confirm these findings. conclusion: omega-3 fatty acids may improve symptoms associated with nafld, but more studies should be done in this area.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease

Background & Objective: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of nonalcoholic steatohepatitis (NASH) and cirrhosis in Iran. M...

full text

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome since obesity and insulin resistance are the main pathogenic contributors for both conditions. NAFLD carries increased risk of atherosclerosis and cardiovascular diseases. There is an urgent need to find effective and safe therapy for children and adults with NAFLD. Data from research and clinica...

full text

Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good?

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent hepatic problem in Western and Asian countries where it can affect more than 30% of people [1]. NAFLD pathological characteristic is a fat infiltration of the hepatocytes (hepatic steatosis) in subjects who are mild or no alcohol drinkers and do not have other secondary causes of hepatic lipid accumulation. In one fifth of affected...

full text

Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome with the main characteristic of diffuse liver cells with fatty changes. The clinical evolution of NAFLD includes simple non-alcoholic fatty liver, non-alcoholic steatohepatitis (NASH), liver fibrosis and cirrhosis, and even hepatocellular carcinoma. METHODS AND FINDINGS We conducted this review to identify the effecti...

full text

Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease describes a range of conditions caused by a build-up of fat within liver cells. It is very common and in many cases is linked to being obese or overweight. Most people with non-alcoholic fatty liver disease do not develop serious liver problems. In some people, the build-up of fat in the liver can lead to serious liver disease. However, all people with non-alco...

full text

Non-Alcoholic Fatty Liver Disease

Results: The term “non-alcoholic fatty liver disease” covers cases of a wide spectrum of severity, ranging from bland fatty liver without any inflammation and with little or no tendency to progress all the way to non-alcoholic steato hepatitis (NASH) with inflammatory reactions and hepatocyte damage, with or without fibrosis. Some 5% to 20% of patients with NAFLD develop NASH, which undergoes a...

full text

My Resources

Save resource for easier access later


Journal title:
تحقیقات نظام سلامت

جلد ۹، شماره ۳، صفحات ۲۵۹-۲۶۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023